Want to see HK:6699 full AI Analyst Report?
Angelalign Technology Inc. (6699) AI Stock Analysis
Top Page
Angelalign Technology Inc.
(HKEX:6699)
The score is primarily supported by strong financial quality (very low leverage) and solid cash generation alongside improving operating performance. Technicals are moderately positive with the stock above key long-term moving averages. The main offset is valuation, with a high P/E and limited dividend yield.
Angelalign Technology Inc. (6699) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 13.14B
- Dividend Yield
- 1.24%
- Average Volume (3M)
- 592.85K
- Price to Earnings (P/E)
- 39.1
- Beta (1Y)
- 0.80
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Hong Kong
- Employees
- 4,478
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Angelalign Technology Inc. Business Overview & Revenue Model
Company Description
Angelalign Technology Inc. functions as an investment holding enterprise primarily dedicated to the innovation, production, and distribution of clear aligner solutions for orthodontic treatment throughout China. Their key offerings, Angel Aligner Pro...
Angelalign Technology Inc. Financial Statement Overview
Summary
Strong financial stability with extremely low leverage and a large equity base, plus robust TTM operating cash flow (~795M) and free cash flow (~624M). Revenue growth is steady (+7.2% TTM) and operating margins have improved, but net margin remains modest (~7.7%) and profitability/returns are still below prior peaks.
Income Statement
76PositiveBalance Sheet
88Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.05B | 2.59B | 1.96B | 1.48B | 1.27B | 1.27B |
| Gross Profit | 1.92B | 1.60B | 1.23B | 920.71M | 785.69M | 826.65M |
| EBITDA | 525.06M | 293.27M | 110.87M | 154.39M | 318.65M | 372.47M |
| Net Income | 283.84M | 199.13M | 88.42M | 53.48M | 213.78M | 285.85M |
Balance Sheet | ||||||
| Total Assets | 5.36B | 5.34B | 4.95B | 4.76B | 4.49B | 4.14B |
| Cash, Cash Equivalents and Short-Term Investments | 2.82B | 3.00B | 436.83M | 3.44B | 3.65B | 3.63B |
| Total Debt | 573.49M | 114.00M | 14.48M | 65.28M | 28.20M | 30.29M |
| Total Liabilities | 2.54B | 1.82B | 1.44B | 1.35B | 884.01M | 826.11M |
| Stockholders Equity | 2.80B | 3.49B | 3.46B | 3.34B | 3.61B | 3.32B |
Cash Flow | ||||||
| Free Cash Flow | 623.98M | 523.39M | -76.78M | 51.28M | 51.48M | 241.95M |
| Operating Cash Flow | 795.13M | 712.07M | 229.79M | 165.87M | 146.87M | 441.71M |
| Investing Cash Flow | 537.07M | -1.26B | -138.82M | -981.71M | -159.77M | -182.05M |
| Financing Cash Flow | -1.00B | -175.45M | -28.46M | -187.06M | -193.61M | 2.52B |
Angelalign Technology Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6699, the sentiment is Negative. The current price of 76.55 is below the 20-day moving average (MA) of 80.88, below the 50-day MA of 84.75, and above the 200-day MA of 73.84, indicating a neutral trend. The MACD of -2.05 indicates Positive momentum. The RSI at 34.25 is Neutral, neither overbought nor oversold. The STOCH value of 25.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6699.
Angelalign Technology Inc. Peers Comparison
Overall Rating
HK:360080Outperform- HK:669974Outperform
HK:135866Neutral
HK:150164Neutral
HK:106659.9Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:3600 | 80Outperform | HKD 6.79B | 9.96 | 20.11% | 3.85% | 12.50% | 44.44% |
| HK:6699 | 74Outperform | HKD 13.19B | 39.13 | 8.95% | 1.24% | ― | ― |
| HK:1358 | 66Neutral | HKD 1.28B | 26.55 | 1.10% | 7.15% | -1.64% | -68.67% |
| HK:1501 | 64Neutral | HKD 6.34B | 21.57 | 9.64% | 0.87% | 34.94% | 12.99% |
| HK:1066 | 60Neutral | HKD 14.54B | 9.09 | 5.64% | 5.24% | 7.47% | -26.89% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:6699 | Angelalign Technology Inc. | 76.55 | 14.99 | 24.35% | |
| HK:1066 | Shandong Weigao Group Medical Polymer Co Class H | 3.21 | -2.04 | -38.76% | |
| HK:1358 | PW Medtech Group Ltd. | 0.90 | -0.56 | -38.36% | |
| HK:3600 | Modern Dental Group Limited | 7.27 | 2.19 | 43.08% | |
| HK:1501 | Shanghai Kindly Medical Instruments Co., Ltd. Class H | 30.00 | 0.12 | 0.39% |
Angelalign Technology Inc. Corporate Events
Angelalign Shareholders Approve Three-Year RSU Grants for Directors
Angelalign Technology Inc., a Hong Kong-listed orthodontic technology company incorporated in the Cayman Islands, provides clear aligner and related dental solutions to patients and practitioners. Its operations are supported by a mix of executive an...
Angelalign Calls EGM to Approve Three-Year RSU Grants for Top Executives
Angelalign Technology Inc. has called an extraordinary general meeting in Shanghai on September 30, 2026, to seek shareholder approval for a series of restricted share unit grants to key executives. The proposed awards include 208,617 RSUs to Chairma...
Angelalign Awards RSUs as Global Business Drives Profit Surge
Angelalign Technology Inc. has approved the grant of 1,563,929 restricted share units under its post-IPO RSU scheme to 16 grantees, including three executive directors and 13 other employees. The grants are designed as both a one-time, three-year ret...
Angelalign Announces HKD 4.1 Special Dividend for First Half of 2026
Angelalign Technology Inc. has announced a special cash dividend of HKD 4.1 per share for the six-month period ended 30 June 2026, payable in Hong Kong dollars with no applicable withholding tax. The ex-dividend date is set for 10 September 2026, wit...
Angelalign Declares HKD 0.47 Interim Dividend for First Half of 2026
Angelalign Technology Inc. has declared an interim ordinary dividend of HKD 0.47 per share for the six-month period ended 30 June 2026, for the financial year ending 31 December 2026. The dividend will be paid in Hong Kong dollars, with an ex-dividen...
Angelalign’s Global Growth Drives Profit Surge and Shareholder Payouts
Angelalign Technology Inc. reported strong interim results for the six months ended 30 June 2026, driven by rapid growth in clear aligner demand. Total case volume rose 40.2% to 316,609, with global markets outside the Chinese mainland contributing 5...
Angelalign Sets Board Meeting to Approve 2026 Interim Results and Consider Dividend
Angelalign Technology Inc. has scheduled a board meeting for August 31, 2026 to review and approve the unaudited interim results for the six months ended June 30, 2026, and to authorize their publication. The board will also consider the payment of a...
Angelalign forecasts sharp profit and revenue gains on aligner demand
Angelalign Technology Inc. expects a strong interim performance for the six months ended June 30, 2026, with clear aligner case volume rising about 40% to roughly 316,600 and revenue climbing over 40% to around USD229–231 million, while net pro...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 18, 2026